View on GitHub

Pistoia-Alliance-PGO

Pistoia Alliance Pharma General Ontology - One, shared and maintained upper level reference ontology for Pharma.

Class: Indication

A sign, signal, circumstance, or symptom which serves to indicate or point out the cause, pathology, treatment, or issue of an attack of disease; the basis for initiation of a treatment for a disease or of a diagnostic test (causal, or symptomatic, or disease-specific indication). https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C41184

Alternative Descriptions * alt_description_text | | * alt_description_source | |
Aliases * Therapeutic Indication
Examples | Value | Description | --- | --- | | [abnormal blood glucose concentration](https://hpo.jax.org/browse/term/HP:0011015) | too much or too little glucose in the blood). | | [Hypotension](https://hpo.jax.org/browse/term/HP:0002615) | A condition in which the blood pressure in the arteries is abnormally low. |
Annotations | property | value | | --- | --- | | definition_source | https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C41184 | | definition_source_attribution | NCI-Thesaurus (NCIT) | | definition_source_licence | [CC-BY-4.0](https://creativecommons.org/licenses/by/4.0/) | | definition_access_date | 2025-05-30 | | expert_approval_date | 2025-06-12 | | conceptual_clarification | The group acknowledged the complexity of the term 'Indication', which spans both pre-approval (e.g., clinical investigation) and post-approval (e.g., regulatory labeling) contexts. Core challenges in terminology harmonization included-- * The restrictive use of terms such as 'abnormal' or 'pathological', which may unnecessarily narrow the scope. * Differentiation between 'sign' and 'symptom'. * The regulatory distinction between investigational and approved uses of a medicinal product. * The need for a resolvable and publicly licensed URI, a key requirement for incorporation into PGO. While definitions from IDMP-O and CDISC were considered valuable, the absence of resolvable unique identifiers in some cases limited their immediate applicability. Notably, the CDISC glossary version of 'Indication' appears to reuse the NCIt concept C41184, but with a modified definition—raising concerns about versioning and semantic traceability. |
Comments * Conceptual Considerations. The group acknowledged the complexity of the term 'Indication', which spans both pre-approval (e.g. clinical investigation) and post-approval (e.g. regulatory labeling) contexts. Core challenges in terminology harmonization included * The restrictive use of terms such as 'abnormal' or 'pathological', which may unnecessarily narrow the scope. * Differentiation between 'sign' and 'symptom'. * The regulatory distinction between investigational and approved uses of a medicinal product. NB, The need for a resolvable and publicly licensed URI, a key requirement for incorporation into PGO. - While definitions from IDMP-O and CDISC were considered valuable, the absence of resolvable unique identifiers in some cases limited their immediate applicability. Notably, the CDISC glossary version of 'Indication' appears to reuse the NCIt concept C41184, but with a modified definition—raising concerns about versioning and semantic traceability * Evaluation of Candidate Definitions. The following definitions were examined-- * IDMP-O_Indication-- Provides a structured approach, classifying indications as disease/symptom/procedure. Treated more as a classifier than a semantically rich standalone concept.* NCIT_C41184-- Definition-- Viewed as a robust, semantically acceptable candidate. * CDISC Glossary (did not have a URI)-- Offers a practical and clinically-oriented definition. * Text Definition and Label. The NCIT_C41184 definition was retained as the preferred reference due to its formal status, semantic breadth, and identifier accessibility. The CDISC phrasing was also recognized as valuable, especially for clinical trial contexts, and can be treated as an alternative expression of the recommended definition. * Recommendations to the PGO Steering Group 1. Adopt NCIT_C41184 as the authoritative definition for the core concept 'Indication' in the PGO.2. Acknowledge alternate phrasings, such as those from CDISC and IDMP-O, as contextually valid variants; both are resolvable with the same URL.
TODOs ## TODOs * Review preferred sources